title: Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
authors.affiliation: Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
authors.forename: Gudbjörg
authors.initials: G
authors.lastname: Jonsdottir
authors.affiliation: Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
authors.forename: Sigrún H
authors.initials: SH
authors.lastname: Lund
authors.affiliation: Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
authors.forename: Magnus
authors.initials: M
authors.lastname: Björkholm
authors.affiliation: Department of Hematology and Coagulation Disorders, Skåne University Hospital, Malmö, Sweden.
authors.forename: Ingemar
authors.initials: I
authors.lastname: Turesson
authors.affiliation: Department of Radiation Sciences, University of Umeå, Sweden.
authors.forename: Anders
authors.initials: A
authors.lastname: Wahlin
authors.affiliation: Multiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Sham
authors.initials: S
authors.lastname: Mailankody
authors.affiliation: Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: Cecilie
authors.initials: C
authors.lastname: Blimark
authors.affiliation: Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
authors.forename: Malin
authors.initials: M
authors.lastname: Hultcrantz
authors.affiliation: University Health Network, Department of Laboratory Medicine and Pathobiology, Toronto General Hospital, ON, Canada.
authors.forename: Anna
authors.initials: A
authors.lastname: Porwit
authors.affiliation: Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Ola
authors.initials: O
authors.lastname: Landgren
authors.affiliation: Faculty of Medicine, University of Iceland, Reykjavik, Iceland Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden sigurdur.Kristinsson@ki.se.
authors.forename: Sigurdur Y
authors.initials: SY
authors.lastname: Kristinsson
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015331:Cohort Studies; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000209:etiology / Q000401:mortality* / Q000473:pathology; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000209:etiology / Q000401:mortality* / Q000473:pathology; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000209:etiology / Q000401:mortality* / Q000473:pathology; D012042:Registries; D012306:Risk; D016019:Survival Analysis; D013548:Sweden
chemical_list: D000970:Antineoplastic Agents
keywords: multiple myeloma; population-based; second malignancy; survival